Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-02-19

Clinical Trial Update: Glial Fibrillary Acidic Protein (GFAP) and Ubiquitin Carboxy-terminal Hydrolase L1 (UCH-L1) to Exclude Lesions Linked to Significant Traumatic Brain Injuries

View source ↗

Summary

The trial investigates GFAP and UCH-L1 biomarkers to help exclude brain lesions associated with significant traumatic brain injuries, and it is currently recrui…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Centre Hospitalier Princesse Grace | Conditions: Traumatic Brain Injury | Status: RECRUITING